It has been discovered that methylation of MGMT occurs in 40% of tumors in gliomas and CRC, but only in 25% of tumors in non-small cell lung carcinomas (NSCLCs), lymphomas, and head and neck carcinomas (67). Here, MGMT is linked to head and neck carcinoma.